Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data and Duke University to Collaborate on Statin PGx Research

NEW YORK, May 12 (GenomeWeb News) - Clinical Data announced today that it has entered into a five-year research collaboration agreement with the Institute for Genome Sciences & Policy at Duke University to discover genetic variants associated with baseline lipid parameters and the response of these parameters to statins.


Under terms of the agreement, Clinical Data's PGxHealth division will non-exclusively provide Duke with confidential access to its Strength studies, which involved evaluating the response of 679 patients to atorvastatin, pravastatin, simvastatin, lovastatin, and cerivastatin; genotopying approximately 175 genes; and evaluating 700 control patients at baseline. In return, Clinical Data will have the right to evaluate the commercial potential of any findings derived from Duke studies which used Strength clinical and/or genetic databases.


Duke researchers are planning a series to studies to find and validate associations between genetic variants and responses to drugs used for dyslipidemia, or hypercholesterolemia, Clinical Data said. The university is also planning on carrying out similar studies in the areas of hypertension and asthma.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.